Sales of AbbVie’s blockbuster drug Humira peaked at $18.9bn last year and, according to analysts at Evaluate Pharma, the product is expected to generate $15.2bn through to 2024. These figures are ...
December 12, 2006 — Health Canada has approved a pen-like device for administering adalimumab in the treatment of moderate to severe rheumatoid arthritis and psoriatic arthritis; the European ...
AbbVie GK, Eisai Co. and EA Pharma Co. have debuted the HUMIRA Pen, an auto-injector pen meant to help simplify self-injection. The product, which has a rounded pen-type body designed to help patients ...
As widely expected by the pharmaceutical industry, seven pharmaceutical companies are releasing biosimilars of AbbVie's Humira. Boehringer Ingelheim's Cyltezo (adalimumab-adbm), an interchangeable ...
June 27, 2006 — The US Food and Drug Administration (FDA) has approved a pill-swallowing cup to facilitate ingestion of medications and vitamins in patients who have difficulty swallowing; an ...
Pune, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Humira Market report 2021 is the broad study of experts in the industry for development modules, arrangements, movements, and sizes. The report also estimates ...
An announcement early this month by Mark Cuban’s deep discount drug company that it would sell Coherus Biosciences’ biosimilar version of AbbVie’s Humira has the Illinois drugmaker calling foul. In a ...
Q: I take Humira Pen injections every two weeks. I need to find out how to dispose of the needles. L.B. A: Humira’s manufacturer AbbVie offers a free Sharps Mail-Back program to all patients taking ...
Humira (adalimumab) is used to treat several autoimmune conditions. The drug typically stays in your system for a few months after your final dose. This article explains how long Humira may remain in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback